Klonopin (Clonazepam) Addiction: The Three Boxed Warnings, and How Treatment Works

Klonopin is the brand name for clonazepam. It is a benzodiazepine. The FDA’s label approves it for certain seizure disorders and for panic disorder [1]. The same label opens with a boxed warning in three parts. Taken with an opioid, it can cause deep sedation, coma and death. Taken at all, it exposes a person to abuse, misuse and addiction. And taken for a long time, it can cause physical dependence. Stopping it abruptly can then set off withdrawal reactions that can be life-threatening [1].

This page is the hub for Klonopin on this site. It covers what the drug is and what it treats. It covers the three boxed warnings in the label’s own words, and whether the drug is addictive. It covers the side effects and the mixes that turn it into an emergency. It covers what an overdose looks like. It covers how long the drug stays in the body, in the only form a federal source supports. It covers withdrawal in outline, and how treatment works. It names no amount and no schedule. Our page on Klonopin withdrawal takes the withdrawal course on its own. Our hub on benzodiazepine addiction covers the class.

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.

What Klonopin Is, and What It Is Approved to Treat

The label describes Klonopin as a benzodiazepine that contains clonazepam, a Schedule IV controlled substance [1]. Its approved uses are narrower than its reputation. For seizures, it is useful alone or as an add-on for Lennox-Gastaut syndrome, akinetic seizures and myoclonic seizures. It may also be useful for absence seizures that have not responded to another class of drug [1]. For panic disorder, with or without agoraphobia, it is approved outright [1]. The label says its exact mechanism is unknown. It is believed to work by boosting GABA, the brain’s main calming messenger [1].

MedlinePlus lists the forms: a tablet, and a tablet that dissolves in the mouth [2]. It puts the purpose in one line. Clonazepam controls certain types of seizures and treats panic attacks. It works by reducing abnormal electrical activity in the brain [2]. NIDA lists clonazepam among the drugs in this class prescribed for anxiety, acute stress reactions and panic attacks. It notes that clonazepam may also be prescribed for seizure disorders and insomnia [4]. The DEA names Klonopin among the most common drugs in the class, with Valium, Xanax, Halcion and Ativan [6]. How much is prescribed, how often, and for how long are prescriber matters. None of that is repeated here.

The Three Boxed Warnings, in the Label’s Words

The boxed warning is the first thing on the label, and it has three parts [1].

Opioids. Using a benzodiazepine with an opioid may result in profound sedation, respiratory depression, coma and death [1]. The label tells prescribers to reserve the pairing for patients with no adequate other option. It tells them to keep amounts and durations to the minimum, and to watch for slowed breathing and sedation [1]. The reason is mechanical. Klonopin acts at GABA sites. Opioids act mainly at mu receptors. Both systems control breathing, so the one drug can make the other’s effect on breathing much worse [1]. If someone is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.

Abuse, misuse and addiction. The use of benzodiazepines, including Klonopin, exposes users to risks of abuse, misuse and addiction, which can lead to overdose or death [1]. Abuse and misuse commonly involve other drugs, alcohol or illicit substances. That mix is linked to more frequent serious outcomes [1]. Prescribers are told to assess each patient’s risk before prescribing and throughout treatment [1].

Dependence and withdrawal. Continued use of benzodiazepines, including Klonopin, may lead to clinically significant physical dependence [1]. The risks of dependence and withdrawal rise with longer treatment and a higher daily amount [1]. Stopping abruptly, or cutting the amount fast, after continued use may set off acute withdrawal reactions, which can be life-threatening [1].

The FDA required this warning for every drug in the class in September 2020. Its communication says why. Even when taken as prescribed, use of these drugs can lead to misuse, abuse and addiction. Physical dependence can occur when they are taken steadily for several days to weeks, even as prescribed. Stopping abruptly, or reducing too quickly, can result in withdrawal reactions, including seizures, which can be life-threatening [3]. The same communication gives the scale. In 2019, an estimated 92 million benzodiazepine prescriptions were dispensed from U.S. outpatient retail and mail-order pharmacies. Clonazepam was the second most common, at 24 percent, after alprazolam [3].

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.

Is Klonopin Addictive? Misuse, Tolerance and Dependence

The label says Klonopin is a CNS depressant with a potential for abuse and addiction [1]. It keeps the terms apart. Abuse is the intentional, non-medical use of a drug, even once, for its desirable effects. Misuse is the intentional use of a drug for a medical purpose in a way other than prescribed, or by someone it was not prescribed for. Addiction is a cluster of behaviors and physical signs. It may include a strong desire to take the drug, trouble controlling use, and putting drug use ahead of other obligations [1]. Tolerance is a reduced response after repeated use [1]. Physical dependence is an adaptation that shows itself as withdrawal signs when the drug is stopped abruptly or cut sharply [1].

Then the label says the sentence that matters most. Even taking benzodiazepines as prescribed may put patients at risk for abuse and misuse of their medication. Abuse and misuse may lead to addiction [1]. Abuse and misuse often, but not always, involve amounts above the maximum the label allows. They commonly involve other medications, alcohol or illicit drugs [1]. These drugs are often sought by people who abuse other drugs, and by people with addictive disorders [1]. The DEA says the same from the enforcement side. Abuse is frequently associated with adolescents and young adults. It is particularly high among people who use heroin and cocaine. And opioid users often co-abuse benzodiazepines to enhance euphoria [6].

The label lists what has happened with abuse and misuse of these drugs. The milder list runs from abdominal pain, amnesia and anxiety through aggression, blurred vision, confusion, depression, disinhibition, dizziness, euphoria, poor concentration and memory, irritability, muscle pain, slurred speech and tremors [1]. The severe list is delirium, paranoia, suicidal thoughts and behavior, seizures, coma, breathing difficulty and death. The label adds that death is more often linked to polysubstance use, especially with opioids and alcohol [1].

NIDA gives the class view. Benzodiazepines are usually not prescribed for long-term use, because of the high risk of developing tolerance, dependence or addiction [4]. During the first few days a person usually feels sleepy and uncoordinated. Those effects fade as tolerance develops. Longer use may require more of the drug for the same effect. Continued use can lead to dependence, and to withdrawal when use is reduced or stopped [4]. MedlinePlus says it to the person taking it. Clonazepam may be habit-forming. Your doctor needs to know if you have ever drunk large amounts of alcohol, used street drugs, overused prescription medications, or had depression or another mental illness [2].

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.

Side Effects, the Suicidality Warning and the Dangerous Combinations

The common effects are the ones every depressant produces. MedlinePlus lists drowsiness, dizziness, unsteadiness, problems with coordination, and trouble thinking or remembering [2]. Its serious list is rash, hives, swelling of the eyes, face, lips, tongue or throat, hoarseness, and trouble breathing or swallowing [2]. The label adds that these drugs can impair judgment, thinking and motor skills. People on Klonopin are warned about driving and operating machinery [1]. It also describes paradoxical reactions: agitation, aggression, anger, nightmares, hallucinations and psychoses. These are more likely in children and older adults [1]. In people with more than one type of seizure disorder, Klonopin may make generalized tonic-clonic seizures more frequent, or bring them on [1].

One warning belongs to Klonopin’s other identity, as an antiepileptic drug. The label says antiepileptic drugs, including Klonopin, increase the risk of suicidal thoughts or behavior in patients taking them for any reason [1]. In the pooled analysis the label reports, patients on one of these drugs had approximately twice the risk of suicidal thinking or behavior compared with placebo. The increase was seen as early as one week after starting [1]. The label’s instruction is plain. Patients, caregivers and families should watch for new or worsening depression, unusual changes in mood or behavior, or thoughts of self-harm, and report them at once [1].

Two more groups get a sentence each. Use of Klonopin late in pregnancy can result in sedation or withdrawal symptoms in the newborn. The label names slowed breathing, low muscle tone, irritability, tremors and feeding difficulties [1]. Breastfeeding patients are told to watch their infants for excessive sleepiness, poor feeding and poor weight gain [1].

The mixes are the part that kills people. The label’s instruction on alcohol is one line. Patients should be advised to avoid alcohol while taking Klonopin [1]. The FDA’s class communication is just as short. Do not drink alcohol with benzodiazepines, because it can increase the risk of serious and life-threatening side effects [3]. MedlinePlus opens its warning with the same pairing the boxed warning does. Clonazepam may cause serious or life-threatening breathing problems, drowsiness or coma if used with certain medications, and it names medications for cough or pain [2]. Unusual dizziness, extreme sleepiness, slowed or difficult breathing, or being unable to respond on that mix is a reason to get emergency care [2].

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.

Klonopin Overdose: What It Looks Like and What to Do

The label’s description is direct. Benzodiazepine overdose is central nervous system depression, ranging from drowsiness to coma [1]. In mild to moderate cases the signs are drowsiness, confusion, slurred speech, lethargy, a hypnotic state, weak reflexes, unsteadiness and low muscle tone [1]. Rarely, the opposite happens: agitation, irritability, impulsive or violent behavior, restlessness and excitement [1]. In severe cases, patients may develop respiratory depression and coma [1]. Overdose together with other depressants, including alcohol and opioids, may be fatal [1]. MedlinePlus lists the signs as drowsiness, confusion and coma [2]. The DEA adds extreme drowsiness, impaired coordination, decreased reflexes, respiratory depression, coma and possible death [6].

What happens in a hospital is on the label too. It is worth reading, because the reversal drug is not the simple answer it sounds like. The label says the care for this overdose is general supportive care, including IV fluids and keeping the airway open [1]. Flumazenil is a benzodiazepine antagonist. It is indicated for reversing the sedative effects of benzodiazepines in overdose [1]. In the same passage the label says flumazenil can lead to withdrawal and adverse reactions, including seizures. That risk is higher when other drugs that raise seizure risk are involved, and in long-term users with physical dependence [1]. The risk of withdrawal seizures may be higher in people with epilepsy. Flumazenil is contraindicated in anyone who received a benzodiazepine to control a life-threatening condition such as status epilepticus [1]. If it is used, the label says, it is an adjunct to supportive care, not a substitute for it [1]. That is a decision for the emergency team. It is not a reason to wait.

MedlinePlus’s instruction for any overdose is to call 911 if the person has collapsed, had a seizure, has trouble breathing or cannot be woken [2]. The label adds one more sign. Markedly abnormal blood pressure, heart rate or breathing raises the concern that other drugs or alcohol are involved [1].

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.

How Long Klonopin Stays in Your System

This is a question people ask about every drug. For clonazepam the honest answer is a range, not a number.

What the label says. The elimination half-life of clonazepam is typically 30 to 40 hours [1]. Clonazepam is highly metabolized. Less than 2 percent leaves the body unchanged in the urine. Its main metabolic route converts one chemical group to an amino form, which is then processed further [1]. A half-life is how long it takes the amount in the blood to fall by half. It is a property of the drug and not a detection window. A 30-to-40-hour half-life is why this drug stays in the body longer than the short-acting drugs in its class.

What the federal tables say. SAMHSA’s table of urine detection periods in TIP 47 gives two rows for the benzodiazepine class: 3 to 7 days at a therapeutic amount, and up to 30 days with chronic dosing [8]. Those are class rows, and clonazepam takes its class’s row. The federal workplace drug-testing rule at 49 CFR 40.85 lists nine analyte groups that laboratories must test for. Benzodiazepines are not among them [9]. Specialized tests for them exist. What a particular program, employer or court uses is the thing to ask them.

What a window depends on. SAMHSA says the time a substance can be detected in urine depends on many interacting factors. It names the drug’s chemical properties such as its half-life, its metabolism and excretion routes, the amount, route, frequency and length of use, the sensitivity and specificity of the assay, and individual variation in health, exercise, diet, weight, gender and fluid intake [8]. Given a half-life of more than a day, chronic use is the case where the long end of the class window applies. Our page on how long benzodiazepines stay in your system covers the class table in full.

Figures that circulate for clonazepam from small volunteer studies at a set amount are not this site’s to repeat. None appears here.

Klonopin Withdrawal in Outline

Withdrawal is what physical dependence looks like when the drug stops. With this class of drug, it belongs to the small group of withdrawals that can turn dangerous. SAMHSA’s detox protocol draws the line in one sentence. Unlike alcohol and sedative withdrawal, uncomplicated opioid withdrawal is not life-threatening [7]. Klonopin sits on the dangerous side of that line.

The label lists the acute signs reported with the class: abnormal involuntary movements, anxiety, blurred vision, depersonalization, depression, derealization, dizziness, fatigue, nausea, vomiting, diarrhea, loss of appetite, headache, sensitivity to sound and light, high blood pressure, irritability, insomnia, memory problems, muscle pain and stiffness, panic attacks, restlessness, fast heartbeat and tremor [1]. Its severe list, which includes reactions that can kill, is catatonia, convulsions, delirium tremens, depression, hallucinations, mania, psychosis, seizures and suicidality [1]. People at higher risk are those who take higher amounts and those who have used the drug longer [1]. The label also describes a protracted withdrawal syndrome. Anxiety, cognitive problems, depression, insomnia, motor symptoms, tingling and ringing in the ears can persist beyond 4 to 6 weeks. In some cases they last weeks to more than 12 months [1].

MedlinePlus writes the instruction for the person. Do not stop taking clonazepam, or take fewer doses, without talking to your doctor [2]. The FDA’s class communication says why there is no schedule on this page. No standard benzodiazepine tapering schedule is suitable for all patients. So the prescriber creates a patient-specific plan to reduce the amount gradually, with ongoing monitoring and support [3]. The label says the same for Klonopin: a gradual taper, on a patient-specific plan [1]. SAMHSA supplies the sequencing a clinician works to. Before beginning any tapering regimen, the patient must be fully stabilized. That means all signs and symptoms of withdrawal must be improved [7]. A rate, a percentage and an interval belong to someone who knows the amount, the duration and what else the person takes. This page carries none.

Our page on Klonopin withdrawal covers the symptoms by system, what governs the course and what supervision adds. The FDA’s rule that the plan is patient-specific [3] is the reason our page on the benzodiazepine taper describes how a prescriber builds one rather than printing one. Our overview of withdrawal symptoms covers how this compares across substances.

If someone is having a seizure, is unresponsive or has trouble breathing, call 911. For a mental-health crisis call or text 988.

Treatment for Klonopin Addiction

NIDA’s guidance for this class is short and specific. Patients addicted to CNS depressants such as tranquilizers, sedatives and hypnotics should not attempt to stop taking them on their own. Withdrawal from these drugs can be severe and, for certain medications, potentially life-threatening [5]. Research on treating addiction to these drugs is sparse. But people who are dependent on them should undergo medically supervised detoxification, because the amount they take should be reduced gradually [5]. Inpatient or outpatient counseling can help a person through that process [5]. Cognitive-behavioral therapy works on a patient’s thinking, expectations and behaviors while building skills for coping with stress. NIDA says it has been used successfully to help people adapt to stopping benzodiazepines [5]. Because depressant misuse often occurs alongside alcohol or opioids, treatment should address the multiple addictions together [5]. And there are no FDA-approved medications for treating addiction to CNS depressants, though research is ongoing [5].

The label points the same way from the prescriber’s chair. If a substance use disorder is suspected, evaluate the patient and start, or refer them for, early treatment [1].

That maps onto the levels of care in a plain way. Our page on medical detox explains what makes a detox medical and which substances need one. SAMHSA’s protocol is clear that detox is not substance abuse treatment and rehabilitation. A detox program is not designed to resolve the longstanding psychological, social and behavioral problems associated with alcohol and drug use [10]. Our guide to the levels of care sets out the five treatment levels that follow. Our page on inpatient rehab describes the most structured of them. Our page on outpatient rehab describes the lighter end. Our overview of the types of therapy and our page on cognitive behavioral therapy cover the counseling NIDA names. Our overview of medication-assisted treatment explains what those drugs are for. NIDA’s sentence above explains why none is approved for this class.

The practical questions settle faster than people expect. Our page on how long rehab takes covers length of stay. Our page on how much rehab costs gives our own published price ranges by level of care. Our guide to insurance coverage covers what a plan decides. Our guide to the admissions process sets out what a program needs before it can give someone a date. Our page on what the rehab process is like walks through a stay. Our treatment center directory has a map you can browse by state. Our hub on prescription drug addiction covers the wider class.

Frequently Asked Questions

Sources

1. U.S. Food and Drug Administration. (2023). KLONOPIN (clonazepam) tablets — Full Prescribing Information: Boxed Warning, Clinical Pharmacology (Pharmacokinetics), Indications and Usage, Warnings (Abuse, Misuse, and Addiction; Dependence and Withdrawal Reactions; Suicidal Behavior and Ideation; Neonatal Sedation and Withdrawal Syndrome), Precautions, Drug Abuse and Dependence, Overdosage. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cfa0d79a-843c-4b88-95a1-e9511d649ca1
2. U.S. National Library of Medicine. (2026). Clonazepam. MedlinePlus Drug Information. https://medlineplus.gov/druginfo/meds/a682279.html
3. U.S. Food and Drug Administration. (2020). FDA Requiring Boxed Warning Updated to Improve Safe Use of Benzodiazepine Drug Class — Drug Safety Communication. U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class
4. National Institute on Drug Abuse. (2023). Misuse of Prescription Drugs Research Report — What classes of prescription drugs are commonly misused? (CNS Depressants). National Institute on Drug Abuse. https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/what-classes-prescription-drugs-are-commonly-misused
5. National Institute on Drug Abuse. (2023). Misuse of Prescription Drugs Research Report — How can prescription drug addiction be treated? (Treating Addiction to CNS Depressants). National Institute on Drug Abuse. https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/how-can-prescription-drug-addiction-be-treated
6. Drug Enforcement Administration. (2025). Benzodiazepines — Drug Fact Sheet. U.S. Department of Justice. https://www.dea.gov/factsheets/benzodiazepines
7. Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 4: Physical Detoxification Services for Withdrawal From Specific Substances — Opioids; Benzodiazepines and Other Sedative-Hypnotics. Substance Abuse and Mental Health Services Administration. https://www.ncbi.nlm.nih.gov/books/NBK64116/
8. Center for Substance Abuse Treatment. (2006). Substance Abuse: Clinical Issues in Intensive Outpatient Treatment, TIP 47, Appendix B: Urine Collection and Testing Procedures and Alternative Methods for Monitoring Drug Use — Exhibit B-1. Substance Abuse and Mental Health Services Administration. https://www.ncbi.nlm.nih.gov/books/NBK64092/
9. Legal Information Institute, Cornell Law School. 49 CFR § 40.85 — What are the cutoff concentrations for urine drug tests? Electronic Code of Federal Regulations. https://www.law.cornell.edu/cfr/text/49/40.85
10. Center for Substance Abuse Treatment. (2006). Detoxification and Substance Abuse Treatment, Chapter 1: Overview, Essential Concepts, and Definitions in Detoxification. Substance Abuse and Mental Health Services Administration. https://www.ncbi.nlm.nih.gov/books/NBK64119/

This page is for general information and is not medical advice. Only a licensed clinician who knows your history can tell you what is right for you. If you or someone you know is in immediate danger, call 911. For free, confidential support 24/7, call or text 988.

Author

Kevin Wandler, MD

Chief Medical Officer, The Recovery Village